Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
108 Results Found
Costs of Caring
This Costs of Caring report provides a data-driven assessment of the financial realities faced by hospitals and health systems, and underscores why sustainable affordability solutions must address the structural drivers of cost growth rather than focusing narrowly on hospital prices alone.
New AHA Report: Hospitals Face Increased Challenges and Financial Pressures as They Care for Patients
The AHA released the 2026 edition of its annual Costs of Caring report. It shows hospitals and health systems continue to face increases in the costs of people, supplies, medicines and infrastructure needed to provide care and services to their communities.
2025 The Cost of Caring Report
This report outlines the key trends impacting hospital financial stability in 2025.
CMMI’s New Drug Models and Their Impact on Beneficiaries, Hospitals
The Trump administration has announced a number of agreements with drug companies to lower U.S. drug prices to levels similar to other countries’, and has proposed several new drug payment models through the Center for Medicare & Medicaid Innovation (CMMI).
2023 Costs of Caring
Hospitals appreciate the support and resources that Congress have provided throughout the COVID-19 pandemic; however, additional support is needed to keep hospitals strong so they can continue to provide care to patients and communities.
2024 Costs of Caring
While recent data suggest that some hospital and health system finances have experienced modest stabilization from historic lows in 2022, the hospital field is still far from where it needs to be to meet the demand for care, invest in new and promising technologies and interventions, and stand ready for the next health care crisis.
AHA comments to CMS on GLOBE payment model
The AHA commented today on the Centers for Medicare & Medicaid Services’ proposed rule on t
ASPR announces investment to increase domestic production of essential drugs
The Administration for Strategic Preparedness and Response Feb. 18 announced an investment that will focus on resolving a frequent shortage of oseltamivir, also known as Tamiflu.
Fact Sheet: 340B Drug Pricing Program Contract Pharmacy Arrangements
Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for patients in vulnerable communities.
House subcommittee hearing discusses impacts of drug pricing on health care costs
The House Energy and Commerce Subcommittee on Health today hosted a hearing titled “Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain.”